Phase variation as a major mechanism of adaptation in <i>Mycobacterium tuberculosis</i> complex.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37399390.
- Also identified by DOI 10.1073/pnas.2301394120 and PMC identifier 10334774.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Phase variation induced by insertions and deletions (INDELs) in genomic homopolymeric tracts (HT) can silence and regulate genes in pathogenic bacteria, but this process is not characterized in MTBC (<i>Mycobacterium tuberculosis</i> complex) adaptation. We leverage 31,428 diverse clinical isolates to identify genomic regions including phase-variants under positive selection. Of 87,651 INDEL events that emerge repeatedly across the phylogeny, 12.4% are phase-variants within HTs (0.02% of the genome by length). We estimated the in-vitro frameshift rate in a neutral HT at 100× the neutral substitution rate at [Formula: see text] frameshifts/HT/year. Using neutral evolution simulations, we identified 4,098 substitutions and 45 phase-variants to be putatively adaptive to MTBC (<i>P</i> < 0.002). We experimentally confirm that a putatively adaptive phase-variant alters the expression of <i>espA,</i> a critical mediator of ESX-1-dependent virulence. Our evidence supports the hypothesis that phase variation in the ESX-1 system of MTBC can act as a toggle between antigenicity and survival in the host.
Medical subject headings
- Mycobacterium tuberculosis